BMC Infectious Diseases 23, 747 (2023)
https://doi.org/10.1186/s12879-023-08714-x
The original publication of this article contained an incorrect caption for Fig. 1. The incorrect and correct information is listed in this correction article. The original article has been updated.
Incorrect
(A) Daily cases during the period of the prospective study of Omicron-infected patients Bracket marks the period when cases were studied. Genomic sequencing of 1 out of 3 patients during this time period revealed 99.2% of cases were the Omicron BA1 variant. (B) Percentage of Delta and Omicron-infected patients who had the reported symptoms associated with their infection. ** p < 0.001 (see Table 1 for statistical analysis). (C) Percentage of Delta and Omicron-infected patients who received each treatment * p = 0.039 − 0.009. ** p = < 0.001 (See Table 1 for statistical analysis). (D) Rothman index scores on admission and at the time of death for Omicron and Delta-infected patients who died in the hospital. Bracket marks the statistically significant difference in admission Rothman Index scores, Delta scores being higher (better overall health) than Omicron cases, Mean ± SD 58.2 ± 26.9 n = 8 vs. 34.8 ± 23.0 n = 34. *p = 0.0158.
Correct
(A) Daily cases during the period of the prospective study of Omicron-infected patients Bracket marks the period when cases were studied. Genomic sequencing of 1 out of 3 patients during this time period revealed 99.2% of cases were the Omicron BA1 variant. (B) Percentage of Delta and Omicron-infected patients who had the reported symptoms associated with their infection. ** p < 0.001 (see Table 1 for statistical analysis). (C) Rothman index scores on admission and at the time of death for Omicron and Delta-infected patients who died in the hospital. Bracket marks the statistically significant difference in admission Rothman Index scores, Delta scores being higher (better overall health) than Omicron cases, Mean ± SD 58.2 ± 26.9 n = 8 vs. 34.8 ± 23.0 n = 34. *p = 0.0158(D) Percentage of Delta and Omicron-infected patients who received each treatment * p = 0.039 − 0.009. ** p = < 0.001 (See Table 1 for statistical analysis).
Reference
Radhakrishnan N, et al. Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service. BMC Infectious Diseases. 2023;23:747. https://doi.org/10.1186/s12879-023-08714-x5.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Radhakrishnan, N., Liu, M., Idowu, B. et al. Correction: Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service. BMC Infect Dis 23, 870 (2023). https://doi.org/10.1186/s12879-023-08827-3
Published:
DOI: https://doi.org/10.1186/s12879-023-08827-3